![Corona hat allen die Notwendigkeit der Digitalisierung im Gesundheitsmarkt verstärkt vor Augen geführt“ - Seite 3 von 8 Corona hat allen die Notwendigkeit der Digitalisierung im Gesundheitsmarkt verstärkt vor Augen geführt“ - Seite 3 von 8](https://www.goingpublic.de/wp-content/uploads/2020/09/GP_04.08.2020_004_Felix-Lorenz-Head-of-Captain-T-Cell-scaled.jpg)
Corona hat allen die Notwendigkeit der Digitalisierung im Gesundheitsmarkt verstärkt vor Augen geführt“ - Seite 3 von 8
![BioInnovation Spotlight at LifeScience ORG with Felix Lorenz on Captain T Cell's therapy for solid tumours - BioInnovator Spotlight BioInnovation Spotlight at LifeScience ORG with Felix Lorenz on Captain T Cell's therapy for solid tumours - BioInnovator Spotlight](https://artwork.captivate.fm/170c87df-90e3-40f5-a1df-204bc212d01b/vGD3vGtMhUz_7Ai-KTLrFFSJ.jpg)
BioInnovation Spotlight at LifeScience ORG with Felix Lorenz on Captain T Cell's therapy for solid tumours - BioInnovator Spotlight
![Targeting Solid Tumours with T-Cells, with Felix Lorenz of Captain T-Cell | BioInnovator Spotlight | Podcasts on Audible | Audible.com Targeting Solid Tumours with T-Cells, with Felix Lorenz of Captain T-Cell | BioInnovator Spotlight | Podcasts on Audible | Audible.com](https://m.media-amazon.com/images/I/41sUoX6JZVL._SL10_UR1600,800_CR200,50,1024,512_CLa%7C1024,512%7C41sUoX6JZVL.jpg%7C0,0,1024,512+97,64,320,320_PJAdblSocialShare-Gradientoverlay-twitter-smallasin-0to60,TopLeft,0,0_PJAdblSocialShare-AudibleLogo-Medium,TopLeft,490,223_OU01_ZBLISTENING%20ON,483,152,55,450,AudibleSansMd,32,255,255,255_PJAdblSocialShare-PodcastIcon-Small,TopLeft,929,45_ZBTargeting%20Solid%20Tum...,96,417,54,320,AudibleSansMd,24,255,255,255.jpg)
Targeting Solid Tumours with T-Cells, with Felix Lorenz of Captain T-Cell | BioInnovator Spotlight | Podcasts on Audible | Audible.com
![A2 Bio Publishes Key Preclinical Findings Demonstrating Potential of Its Highly Selective Tmod™ Cell Therapy Platform to Revolutionize the Treatment of Solid Tumors in Select Patients | Business Wire A2 Bio Publishes Key Preclinical Findings Demonstrating Potential of Its Highly Selective Tmod™ Cell Therapy Platform to Revolutionize the Treatment of Solid Tumors in Select Patients | Business Wire](https://mms.businesswire.com/media/20220302005008/en/1372754/5/A2_Bio_LinkedIn_Tmod_video_2022FEB23_V02_D.jpg)